Detalhe da pesquisa
1.
Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries.
J Antimicrob Chemother
; 71(2): 367-71, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26518047
2.
Cardiovascular autonomic function tests in an African population.
BMC Endocr Disord
; 8: 19, 2008 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19115999
3.
Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients.
PLoS One
; 12(7): e0180140, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28727795
4.
HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014.
PLoS One
; 12(2): e0171227, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28207816
5.
Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden.
Lancet HIV
; 3(4): e166-74, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27036992
6.
Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
AIDS Res Hum Retroviruses
; 31(8): 830-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26059763
7.
Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.
PLoS One
; 10(3): e0118643, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25785448
8.
Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades.
PLoS One
; 9(6): e99390, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24922326
9.
HIV care in the Swedish-Danish HIV cohort 1995-2010, closing the gaps.
PLoS One
; 8(8): e72257, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23967292
10.
Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011.
PLoS One
; 8(3): e59337, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23533618